Skip to content
Clinical Trials – home
Research site

Centrum klinickeho vyzkumu s.r.o.

Czechia Cechovska 57, 261 01 Příbram, Czechia

  • Arteriosclerosis · Atrial fibrillation
  • Adult patients

About Specializations

Centrum klinickeho vyzkumu s.r.o. in Příbram, Czechia specialises in clinical trials of conditions such as Arteriosclerosis, Atrial fibrillation, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

The department investigates atherosclerotic cardiovascular disease and elevated Lipoprotein(a), aiming to test new agents that may lower the incidence of coronary heart disease death, myocardial infarction, and urgent revascularization.

  • Atherosclerotic cardiovascular disease
  • Coronary heart disease death
  • Myocardial infarction
  • Urgent coronary revascularization
  • Lipoprotein(a) reduction

Centrum klinickeho vyzkumu s.r.o. collaborates with local investigators to evaluate the effectiveness of novel therapies for heart health.

Nutritional and Metabolic Diseases

The research program addresses obesity and overweight, evaluating the potential of tirzepatide to reduce morbidity and mortality linked to excess weight and metabolic dysfunction.

  • Obesity management
  • Weight reduction strategies
  • Metabolic risk improvement
  • Morbidity and mortality outcomes
  • Dual GLP‑GIP agonist therapy

As a commercial organization, the site accelerates the translation of metabolic research into accessible patient solutions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Cechovska 57261 01 PříbramCzechia
Recruiting now
no trials
Conditions studied
2

More sites in PříbramCzechia

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.